RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SINIGAGLIA L
Collezione AO Ordine Mauriziano

Items : 10

Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2022 Nov;40(11):2038-2043. doi: 10.55563/clinexprheumatol/fmyozh. Epub 2022 Mar

2022
AO Ordine Mauriziano

Zanetti A; Carrara G; Landolfi G; Rozza D; Chighizola CB; Alunno A; Andreoli L; Caporali R; Gerli R; Sebastiani GD; Valesini G; Sinigaglia L; Raffeiner B; Lomater C; Caprioli M; Fredi M; Romeo N; Cuomo G; Vadacca M; Scirè CA;

Impact of one-year treatment with biotechnological drugs on work ability in patients with rheumatoid arthritis in Italy: a prospective real-life study. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2021 Mar-Apr;39(2):263-268. doi: 10.55563/clinexprheumatol/q69z52. Epub 2020 Jun

2021
AOU Alessandria
AO Ordine Mauriziano

Stobbione P; Capri S; Sinigaglia L; Sarzi-Puttini P; Fusaro E; Gorla R; Lomater C; Caporali R; Manara M;

COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19). in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 Jul-Aug;38(4):748-753. Epub 2020 Jul 28.

2020
AO Cuneo
AO Ordine Mauriziano

Valesini G; Sinigaglia L; Gerli R; Sebastiani GD; Caporali R; Alunno A; Andreoli L; Landolfi G; Chighizola C; Carrara G; Zanetti A; Scirè CA;

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. in Journal of clinical medicine / J Clin Med. 2019 Nov 18;8(11):2013. doi: 10.3390/jcm8112013.

2019
AO Ordine Mauriziano

Cavagna L; Trallero-Araguás E; Meloni F; Cavazzana I; Rojas-Serrano J; Feist E; Zanframundo G; Morandi V; Meyer A; Pereira da Silva JA; Matos Costa CJ; Molberg O; Andersson H; Codullo V; Mosca M; Barsotti S; Neri R; Scirè C; Govoni M; Furini F; Lopez-Longo FJ; Martinez-Barrio J; Schneider U; Lorenz HM; Doria A; Ghirardello A; Ortego-Centeno N; Confalonieri M; Tomietto P; et alii...

Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry. in International journal of rheumatic diseases / Int J Rheum Dis. 2018 Feb;21(2):422-430. doi: 10.1111/1756-185X.13199. Epub 2017 Oct 30.

2018
AO Ordine Mauriziano

Favalli EG; Sinigaglia L; Becciolini A; Grosso V; Gorla R; Bazzani C; Atzeni F; Sarzi Puttini PC; Fusaro E; Pellerito R; Caporali R;

Using a modified Delphi process to establish clinical consensus for the diagnosis, risk assessment and abatacept treatment in patients with aggressive rheumatoid arthritis. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2017 Sep-Oct;35(5):772-776. Epub 2017 Mar 3.

2017
AO Ordine Mauriziano

Caporali R; Carletto A; Conti F; D'Angelo S; Foti R; Gremese E; Govoni M; Iannone F; Pellerito R; Sinigaglia L;

Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2017 Sep-Oct;35(5):804-809. Epub 2017 Jul 27.

2017
AO Ordine Mauriziano

Manara M; Caporali R; Favalli EG; Grosso V; Atzeni F; Sarzi Puttini P; Gorla R; Bazzani C; Fusaro E; Pellerito R; Rocchetta PA; Sinigaglia L;

Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2017 Jul-Aug;35(4):660-665. Epub 2017 May 8.

2017
AO Ordine Mauriziano

Codullo V; Iannone F; Sinigaglia L; Favalli EG; Sarzi-Puttini P; Atzeni F; Ferraccioli G; Gremese E; Carletto A; Giollo A; Govoni M; Bergossi F; Galeazzi M; Cantarini L; Salaffi F; Di Carlo M; Bazzani C; Pellerito R; Sebastiani M; Ramonda R; Lapadula G; Caporali R;

Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability. in Clinical rheumatology / Clin Rheumatol. 2016 Nov;35(11):2649-2656. doi: 10.1007/s10067-016-3349-z. Epub 2016 Jul 14.

2016
AO Ordine Mauriziano

Iannone F; Sinigaglia L; Favalli EG; Sarzi-Puttini P; Atzeni F; Caporali R; Codullo V; Ferraccioli G; Gremese E; Carletto A; Giollo A; Govoni M; Bergossi F; Galeazzi M; Cantarini L; Salaffi F; Di Carlo M; Bazzani C; Pellerito R; Sebastiani M; Ramonda R; Lapadula G;

Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2015 Nov-Dec;33(6):895-9. Epub 2015 Dec 15.

2015
AO Ordine Mauriziano

Idolazzi L; Adami S; Capozza R; Bianchi G; Cozzolongo A; Epis O; Fusaro E; Lapadula G; Migliore A; Pellerito R; Pucino A; Sinigaglia L; Visalli E; Rossini M;